YKL-1-116 is a selective, covalent inhibitor of cyclin-dependent kinase 7 (CDK7) used in laboratory research to probe CDK7-dependent cell cycle and transcriptional processes. It is more potent than related inhibitors against CDK7 and shows limited activity against CDK9, CDK12, and CDK13. Supplied as a small, high-purity solid for research use only (not for human consumption).
- Selective covalent inhibitor of CDK7.
- Higher potency against CDK7 compared with related compounds.
- Minimal activity against CDK9, CDK12, and CDK13.
- High reported purity (~98.7%).
- Provided as a small solid quantity suitable for in vitro research.
- Molecular weight 606.72 and formula C34H38N8O3.